OTCMKTS:ABCZY ABCAM PLC/ADR Stock Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding ABCAM PLC/ADR Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $15.70 +0.57 (+3.77 %) (As of 09/24/2020 12:00 AM ET) Add Compare Share Today's Range$15.13Now: $15.70▼$15.7550-Day Range$14.56MA: $17.00▼$18.0652-Week Range$11.26Now: $15.70▼$19.73Volume10,332 shsAverage Volume4,275 shsMarket Capitalization$3.22 billionP/E Ratio37.38Dividend Yield0.46%Beta1.29 ProfileAnalyst RatingsChartCompetitorsDividendHeadlinesShort InterestSocial Media Abcam plc, together with its subsidiaries, produces and distributes research-grade antibodies and associated protein research tools worldwide. The company primarily offers primary and secondary antibodies; ELISA, matched antibody pairs and multiplex immunoassays; cell and tissue imaging tools; cellular and biochemical assays; proteins and peptides; proteomics tools; agonists, antagonists, activators, and inhibitors; lysates; and multiplex miRNA assays. Its products are used in the areas of cancer, cardiovascular, cell biology, developmental biology, epigenetics, immunology, metabolism, microbiology, neuroscience, signal transduction, and stem cells. The company also sells its products online. Abcam plc was founded in 1998 and is based in Cambridge, the United Kingdom.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for ABCAM PLC/ADR. Previous Next 2.0 Community Rank Outperform VotesABCAM PLC/ADR has received 89 “outperform” votes. (Add your “outperform” vote.)Underperform VotesABCAM PLC/ADR has received 139 “underperform” votes. (Add your “underperform” vote.)Community SentimentABCAM PLC/ADR has received 60.96% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about ABCAM PLC/ADR and other stocks. Vote “Outperform” if you believe ABCZY will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ABCZY will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 1.7 Dividend Strength Dividend YieldABCAM PLC/ADR has a dividend yield of 0.46%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthABCAM PLC/ADR does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of ABCAM PLC/ADR is 16.67%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, ABCAM PLC/ADR will have a dividend payout ratio of 25.00% next year. This indicates that ABCAM PLC/ADR will be able to sustain or increase its dividend. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, ABCAM PLC/ADR insiders have not sold or bought any company stock. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for ABCAM PLC/ADR are expected to grow by 33.33% in the coming year, from $0.21 to $0.28 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of ABCAM PLC/ADR is 37.38, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 18.26.Price to Earnings Ratio vs. SectorThe P/E ratio of ABCAM PLC/ADR is 37.38, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 26.33. Previous Next Analyst Opinion: 0.0Community Rank: 2.0Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.98 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Industrial inorganic chemicals, not elsewhere classified Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:ABCZY Previous SymbolNASDAQ:ABCZY CUSIPN/A CIKN/A WebN/A PhoneN/ADebt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E Ratio37.38 Forward P/E Ratio74.76 P/E GrowthN/A Sales & Book Value Annual Sales$336.37 million Price / Sales9.57 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees1,100 Outstanding Shares205,080,000Market Cap$3.22 billion Next Earnings Date9/25/2020 (Estimated) OptionableNot Optionable $15.70 +0.57 (+3.77 %) (As of 09/24/2020 12:00 AM ET) 30 days | 90 days | 365 days | Advanced Chart Receive ABCZY News and Ratings via Email Sign-up to receive the latest news and ratings for ABCZY and its competitors with MarketBeat's FREE daily newsletter. ABCAM PLC/ADR (OTCMKTS:ABCZY) Frequently Asked Questions How has ABCAM PLC/ADR's stock been impacted by COVID-19 (Coronavirus)? ABCAM PLC/ADR's stock was trading at $14.83 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, ABCZY stock has increased by 5.9% and is now trading at $15.70. View which stocks have been most impacted by COVID-19. Do Wall Street analysts recommend investors buy shares of ABCAM PLC/ADR? 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ABCAM PLC/ADR in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for ABCAM PLC/ADR. When is ABCAM PLC/ADR's next earnings date? ABCAM PLC/ADR is scheduled to release its next quarterly earnings announcement on Friday, September 25th 2020. View our earnings forecast for ABCAM PLC/ADR. How often does ABCAM PLC/ADR pay dividends? What is the dividend yield for ABCAM PLC/ADR? ABCAM PLC/ADR announced a Semi-Annual dividend on Tuesday, March 10th. Stockholders of record on Friday, March 20th will be paid a dividend of $0.037 per share on Friday, May 1st. The ex-dividend date is Thursday, March 19th. View ABCAM PLC/ADR's dividend history. Are investors shorting ABCAM PLC/ADR? ABCAM PLC/ADR saw a decline in short interest during the month of August. As of August 31st, there was short interest totaling 6,000 shares, a decline of 47.4% from the August 15th total of 11,400 shares. Based on an average daily trading volume, of 6,200 shares, the short-interest ratio is currently 1.0 days. View ABCAM PLC/ADR's Short Interest. Who are some of ABCAM PLC/ADR's key competitors? Some companies that are related to ABCAM PLC/ADR include Smith & Nephew (SN), Avantor (AVTR), Masimo (MASI), ABIOMED (ABMD), Qiagen (QGEN), GRIFOLS S A/S (GRFS), PPD (PPD), Sartorius (SARTF), argenx (ARGX), Dr.Reddy's Laboratories (RDY), Recordati (RCDTF), Oak Street Health (OSH), Sarepta Therapeutics (SRPT), Guardant Health (GH) and Charles River Laboratories Intl. (CRL). View all competitors. Who are ABCAM PLC/ADR's key executives? ABCAM PLC/ADR's management team includes the following people: Mr. Alan Thomas Hirzel BS, MS, MBA, CEO & Exec. Director (Age 51)Dr. Jonathan Simon Milner, Co-Founder & Non-Exec. Deputy Chairman (Age 54)Mr. Gavin Hilary James Wood BA (Hons), ACA, CFO & Exec. Director (Age 49)James Staveley, VP of Investor RelationsMr. Nick Skinner, Sr. VP of HR What is ABCAM PLC/ADR's stock symbol? ABCAM PLC/ADR trades on the OTCMKTS under the ticker symbol "ABCZY." How do I buy shares of ABCAM PLC/ADR? Shares of ABCZY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is ABCAM PLC/ADR's stock price today? One share of ABCZY stock can currently be purchased for approximately $15.70. How big of a company is ABCAM PLC/ADR? ABCAM PLC/ADR has a market capitalization of $3.22 billion and generates $336.37 million in revenue each year. ABCAM PLC/ADR employs 1,100 workers across the globe. This page was last updated on 9/25/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
